Home > Press > New York City Bar Association holds nanotech patent panel
New York City Bar Association holds nanotech patent panel
Posted on June 12, 2006
Nanotechnology Patent Law
Monday, June 19, 2006 at 6:30 p.m.
The Science & Law Committee and Patents Committee invite you to a panel discussion about nanotechnology, the science of manipulating matter at the molecular level. The race to patent this new technology has produced a flood of broad and overlapping patents. These "patent thickets" may spur considerable patent litigation and make it challenging for companies to commercialize the revolutionary advances in medicine, electronics, manufacturing and other fields made possible by nanotechnology. This panel discussion will be held at 42 West 44th Street, and is open to the public.
Managing Editor, Nanotechnology Law & Business (New York)
President, Harris & Harris Group, Inc., and Co-Editor-in-Chief, Nanotechnology Law & Business (New York)
Author, The Handbook of Nanotechnology Business, Policy, and Intellectual Property Law, and VP for Intellectual Property at Arrowhead Research (Pasadena)
President, Bawa Biotechnology Consulting LLC (Ashburn, VA), and Patent Agent/Advisor, RPI (Troy, NY)
Director of Patent Operations, Wilson Sonsini Goodrich & Rosati (Reston, VA), and former Deputy Commissioner for Patent Operations, US PTO (Alexandria, VA)
Nanotechnology Subcommittee Chair
Science & Law Committee
New York City Bar
42 West 44th Street, New York, NY 10036
(212) 382-6600, www.nycbar.org
Copyright © New York City Bar
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014
ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014
Unraveling the light of fireflies December 17th, 2014
First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014
Chemists Fabricate Novel Rewritable Paper: An attractive alternate to regular paper, UC Riverside-developed technology helps address increasing problems in environment and resource sustainability December 2nd, 2014
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014
First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014
Ki-Bum Lee Patents Technology To Advance Stem Cell Therapeutics November 13th, 2014